With few new treatment options on the horizon for patients suffering from joint pain associated with hip and knee osteoarthritis, it should come as no surprise that the business of joint replacement is booming and will continue to do so for the foreseeable future. Even in the current economic environment where elective joint replacement procedures are likely to slow down, there has not (yet) been a significant impact on implant sales.The industry admits it is not immune to the global economic crisis, at least in the short term. However, over the long haul, the general consensus is that this market will remain strong owing to solid growth in the patient pool.
by Sharon O’Reilly
For more than half a century, total joint replacement (TJR) has enabled millions of Americans with debilitating arthritic hips and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
The pulsed-field ablation market is surging, with the UK NHS opening doors and FDA updates for major players. Medtech Insight spoke with Steven Mickelsen, founder of Farapulse (the first clinically approved PFA system), about the sector's growth and his new venture, Field Medical.